Matthijs Versteegh - Search Results

Year	Number of Results
2010	1
2011	2
2012	5
2013	6
2015	2
2016	3
2017	2
2018	2
2019	6
2020	5
2021	9
2022	9
2023	16
2024	1

1

[Loss is gain? Discarding TNF-α inhibitors].

Versteegh MM, Attema AE, Uyl-de Groot CA. Versteegh MM, et al. Ned Tijdschr Geneeskd. 2019 Mar 21;163:D3709. Ned Tijdschr Geneeskd. 2019. PMID: 30945830 Review. Dutch.

2

HEcoPerMed, personalized medicine from a health economic perspective: lessons learned and potential opportunities ahead.

Rutten-van Mölken M, Versteegh M, Nagy B, Wordsworth S. Rutten-van Mölken M, et al. Among authors: versteegh m. Per Med. 2023 Jul;20(4):299-303. doi: 10.2217/pme-2022-0074. Epub 2023 Sep 22. Per Med. 2023. PMID: 37736874 Free article. No abstract available.

3

Health-economic benefits of anti-CD20 treatments in relapsing multiple sclerosis estimated using a treatment-sequence model.

Smets I, Versteegh M, Huygens S, Corsten C, Wokke B, Smolders J. Smets I, et al. Among authors: versteegh m. Mult Scler J Exp Transl Clin. 2023 Jul 24;9(3):20552173231189398. doi: 10.1177/20552173231189398. eCollection 2023 Jul-Sep. Mult Scler J Exp Transl Clin. 2023. PMID: 37529628 Free PMC article.

4

The Net Benefit of Personalized Medicine: A Systematic Literature Review and Regression Analysis.

Vellekoop H, Versteegh M, Huygens S, Corro Ramos I, Szilberhorn L, Zelei T, Nagy B, Tsiachristas A, Koleva-Kolarova R, Wordsworth S, Rutten-van Mölken M; HEcoPerMed consortium. Vellekoop H, et al. Among authors: versteegh m. Value Health. 2022 Aug;25(8):1428-1438. doi: 10.1016/j.jval.2022.01.006. Epub 2022 Mar 2. Value Health. 2022. PMID: 35248467 Free article. Review.

5

Benefits of sphingosine-1-phosphate receptor modulators in relapsing MS estimated with a treatment sequence model.

Corsten CEA, Huygens SA, Versteegh MM, Wokke BHA, Smets I, Smolders J. Corsten CEA, et al. Among authors: versteegh mm. Mult Scler Relat Disord. 2023 Dec;80:105100. doi: 10.1016/j.msard.2023.105100. Epub 2023 Oct 22. Mult Scler Relat Disord. 2023. PMID: 37944195 Free article.

6

[The qaly: informing decision-making in health care].

Versteegh M, Dijkgraaf M. Versteegh M, et al. Ned Tijdschr Geneeskd. 2023 Jun 22;167:D7138. Ned Tijdschr Geneeskd. 2023. PMID: 37493301 Dutch.

7

From Good to Better: New Dutch Guidelines for Economic Evaluations in Healthcare.

Versteegh M, Knies S, Brouwer W. Versteegh M, et al. Pharmacoeconomics. 2016 Nov;34(11):1071-1074. doi: 10.1007/s40273-016-0431-y. Pharmacoeconomics. 2016. PMID: 27613159 No abstract available.

8

When is it too expensive? Cost-effectiveness thresholds and health care decision-making.

Brouwer W, van Baal P, van Exel J, Versteegh M. Brouwer W, et al. Among authors: versteegh m. Eur J Health Econ. 2019 Mar;20(2):175-180. doi: 10.1007/s10198-018-1000-4. Eur J Health Econ. 2019. PMID: 30187251 No abstract available.

9

Severity-Adjusted Probability of Being Cost Effective.

Versteegh MM, Ramos IC, Buyukkaramikli NC, Ansaripour A, Reckers-Droog VT, Brouwer WBF. Versteegh MM, et al. Pharmacoeconomics. 2019 Sep;37(9):1155-1163. doi: 10.1007/s40273-019-00810-8. Pharmacoeconomics. 2019. PMID: 31134467 Free PMC article.

10

Methodological Challenges in the Economic Evaluation of a Gene Therapy for RPE65-Mediated Inherited Retinal Disease: The Value of Vision.

Huygens SA, Versteegh MM, Vegter S, Schouten LJ, Kanters TA. Huygens SA, et al. Among authors: versteegh mm. Pharmacoeconomics. 2021 Apr;39(4):383-397. doi: 10.1007/s40273-021-01003-y. Epub 2021 Feb 19. Pharmacoeconomics. 2021. PMID: 33604870 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

58 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

58 results

Results by year